Literature DB >> 11375381

Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes.

C A Hedman, T Lindström, H J Arnqvist.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375381     DOI: 10.2337/diacare.24.6.1120

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  18 in total

1.  Non-equivalent role of inter- and intramolecular hydrogen bonds in the insulin dimer interface.

Authors:  Emília Antolíková; Lenka Žáková; Johan P Turkenburg; Christopher J Watson; Ivona Hančlová; Miloslav Šanda; Alan Cooper; Tomáš Kraus; A Marek Brzozowski; Jiří Jiráček
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: validation and simulation.

Authors:  Jason Wong; J Geoffrey Chase; Christopher E Hann; Geoffrey M Shaw; Thomas F Lotz; Jessica Lin; Aaron J Le Compte
Journal:  J Diabetes Sci Technol       Date:  2008-07

3.  Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation.

Authors:  Ahmad Haidar; Claire Duval; Laurent Legault; Rémi Rabasa-Lhoret
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

Review 4.  A critical appraisal of the role of insulin analogues in the management of diabetes mellitus.

Authors:  Ralph Oiknine; Marla Bernbaum; Arshag D Mooradian
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  The insulin and insulin-like growth factor receptor family in neoplasia: an update.

Authors:  Michael Pollak
Journal:  Nat Rev Cancer       Date:  2012-02-16       Impact factor: 60.716

Review 6.  Insulin analogues: new therapies for type 2 diabetes mellitus.

Authors:  M Angelyn Bethel; Mark N Feinglos
Journal:  Curr Diab Rep       Date:  2002-10       Impact factor: 4.810

Review 7.  Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.

Authors:  Neil A Reynolds; Antona J Wagstaff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: model structure and parameter identification.

Authors:  Jason Wong; J Geoffrey Chase; Christopher E Hann; Geoffrey M Shaw; Thomas F Lotz; Jessica Lin; Aaron J Le Compte
Journal:  J Diabetes Sci Technol       Date:  2008-07

Review 9.  New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations.

Authors:  Paris Roach
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling.

Authors:  Per M Humpert; Zdenka Djuric; Ulf Zeuge; Dimitrios Oikonomou; Yuri Seregin; Klaus Laine; Volker Eckstein; Peter P Nawroth; Angelika Bierhaus
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.